Retaglutide is a cutting-edge GLP-1 receptor agonist currently under study for the treatment of type 2 diabetes. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://henriwvtf683251.p2blogs.com/37505627/trelaglutide-exploring-a-new-therapy-for-chronic-diseases